Rousseau, B. | IICIMED

Rousseau, B.

Publications

P155

Anticancer Res. 2016, 36, 1621-1630.

Discovery of (imidazo[1,2-a]pyrazin-6-yl)ureas as antiproliferative agents targeting P53 in non-small cell lung cancer cell lines.


P138

Sci. Rep. 2015, 5:10356

 TP53 transcription factor to NEDD9/HEF1/Cas-L gene: potential targets in Non Small Cell Lung Cancer treatment.


doi: 10.1038/srep10356

P126

Sci. Rep. 2014, 4:3977.

Screening and discovery of nitro-benzoxadiazole compounds activating epidermal growth factor receptor (EGFR) in cancer cells.


doi: 10.1038/srep03977.

P121

Eur. J. Med. Chem., 2013, 69, 823-832.

Synthesis and antiproliferative activity of benzofuran-based analogs of cercosporamide against non-small cell lung cancer cell lines.


P111

J. Ocul. Pharmacol. Ther. 2012, 28, 299-306. 

Study of antiproliferative effects of synthetic substances against lens epithelial cell line (SRA01/04).


P110

Gene, 2012, 506, 355-9.

miRNAs, a potential target in the treatment of Non-Small Cell Lung Carcinomas.


Autres publications scientifiques

Brevets

Thèse

T29.

TP53 facteur de transcription pour le gène NEDD9/HEF1/Cas-L : nouvelles cibles potentielles dans le traitement du Cancer du Poumon « Non à Petites Cellules ».


Nantes, date de soutenance : 12 décembre 2014.